Basic information on Fullmetron Ophthalmic Suspension 0.1% has been published in the Nikkei Medical Prescription Drug Dictionary, which reportedly compiles an overview of the indicated inflammatory eye diseases, dosage and administration, and package insert.
As an ophthalmic drug with anti-inflammatory and antiallergic effects, it is reportedly used for inflammatory diseases such as blepharitis, conjunctivitis and keratitis, as well as to suppress inflammation after surgery.
The package insert states that 1–2 drops should be instilled 2–4 times daily, with the dosage potentially adjusted according to the patient's age and symptoms.
Serious adverse reactions cited include the possibility of glaucoma, corneal infection and perforation, and posterior subcapsular cataracts. Other listed adverse reactions reportedly include blepharitis, conjunctival hyperemia and corneal deposits.
Contraindications include patients with a history of hypersensitivity to any ingredient in the product. Precautions are specified for administration to pregnant women, children and older adults.
Storage and handling precautions in the package insert reportedly include storage at room temperature, care regarding mixing when shaken, hygiene during instillation and maintaining an interval between this product and other medicines.